ArticleeLife2017

Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Stephen K Horrigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.